Company name: Vert Cannabis
Description: Producer and distributor of medical marijuana intended to offer treatment for patients. The company’s medical marijuana provides treatment for epilepsy, movement disorders, anorexia, chronic pain, asthma, glaucoma, nausea and vomiting, addiction and cravings, autoimmune diseases and inflammations, spasms and psychiatric symptoms, enabling patients to quickly heal for illness.
Year founded: 2013
Parent company: Canopy Growth
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Canopy Growth (TSE: WEED) for an undisclosed amount on November 1, 2016.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: